Discover trends, market shifts, and competitive outlooks for the diphtheria industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Fast Is The Diphtheria Market Expected to Grow Between 2025 And 2029?

The market size of diphtheria has shown robust growth in recent times. The market, which was worth $8.91 billion in 2024, is projected to reach $9.51 billion in 2025, registering a compound annual growth rate (CAGR) of 6.7%. Factors such as vaccine development, immunization drives, heightened awareness, and enhanced healthcare infrastructure have contributed to this growth during the historical period.

Forecasted robust growth in the diphtheria market over the coming years is projected to elevate it to $12.35 billion by 2029, boasting a compound annual growth rate (CAGR) of 6.8%. The anticipated expansion in this timeframe is due to factors such as emerging outbreaks, the implementation of booster vaccination programs, global travel and migration trends, and public health readiness. The pivotal trends during this forecast period consist of combination vaccines, the use of telemedicine for vaccinations, initiatives for vaccine equity, and public-private collaborations.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13016&type=smp

What Are the Core Market Drivers Propelling Growth in the Diphtheria Industry?

The increase in bacterial infection incidents is anticipated to boost diphtheria market growth. A bacterial infection refers to health problems caused by bacterial growth or the toxins they produce within the body. Diphtheria is a serious disease caused by bacterial types that weaken the immune system and stimulate the growth of Corynebacterium diphtheria. For example, the GOV.UK website, a government site of the UK, stated in September 2024 that during the fiscal year 2022 to 2023, NHS acute trusts in England reported 38,757 instances of E. coli bacteremia, with 7,881 (20.3%) recognized as hospital-acquired infections. Consequently, the diphtheria market is being fueled by the growing prevalence of bacterial infections.

Diphtheria Market Driver: The Growth Of The Diphtheria Market Is Fueled By Expanding Immunization Programs

How Is the Diphtheria Market Segmented?

The diphtheria market covered in this report is segmented –

1) By Type: Diphtheria, Skin Diphtheria, Other Types

2) By Diagnosis: Physical Examination, Throat Culture, Other Diagnosis

3) By Treatment: Antibiotics, Antitoxin, Other Treatments

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

5) By End-Users: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Diphtheria: Respiratory Diphtheria, Non-respiratory Diphtheria

2) By Skin Diphtheria: Cutaneous Diphtheria

3) By Other Types: Diphtheritic Myocarditis, Diphtheritic Neuritis

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=13016&type=smp

Which Regions Are Driving the Next Phase of the Diphtheria Market Growth?

Asia-Pacific was the largest region in the diphtheria market in 2024. The regions covered in diphtheria market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Diphtheria Industry?

Key players in the diphtheria market, such as GlaxoSmithKline PLC, are focusing on developing novel drugs and securing approval to maintain their market standing. In October 2022, this UK-based pharma and biotech company reported that the US FDA gave approval to BOOSTRIX (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, adsorbed; Tdap) for immunization during the third month of pregnancy. This is intended to prevent pertussis (also known as whooping cough) in infants under two months old. By giving the Tdap vaccination during pregnancy, maximum protection against whooping cough can be provided to the newborns in their early life stages. This is due to the transfer of protective antibodies from the mother to the child when the mother is immunized during pregnancy.

View the full report here:

https://www.thebusinessresearchcompany.com/report/diphtheria-global-market-report

How Is the Diphtheria Market Defined and What Are Its Core Parameters?

Diphtheria is a bacterial illness caused by strains of bacteria called bacteria Corynebacterium diphtheriae which make a toxin that predominantly affects the mucous membranes of the throat and nose and can also affect other regions of the body in severe instances. It can be identified by throat discomfort, weakness, fever, swollen neck glands, breathing difficulties due to tissues clogging the nose and throat and difficulty in swallowing.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13016

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model